» Articles » PMID: 20001914

The Production and Role of Gastrin-17 and Gastrin-17-gly in Gastrointestinal Cancers

Overview
Specialty Biochemistry
Date 2009 Dec 17
PMID 20001914
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal peptide hormone gastrin is responsible for initiating the release of gastric acid in the stomach in response to the presence of food and/or humoral factors such as gastrin releasing peptide. However, it has a role in the growth and maintenance of the gastric epithelium, and has been implicated in the formation and growth of gastric cancers. Hypergastrinemia resulting from atrophic gastritis and pernicious anemia leads to hyperplasia and carcinoid formation in rats, and contributes to tumor formation in humans. Additionally, gastrin has been suspected to play a role in the formation and growth of cancers of the colon, but recent studies have instead implicated gastrin processing intermediates, such as gastrin-17-Gly, acting upon a putative, non-cholecystokinin receptor. This review summarizes the production and chemical structures of gastrin and of the processing intermediate gastrin-17-Gly, as well as their activities in the gastrointestinal tract, particularly the promotion of colon cancers.

Citing Articles

Postprandial gastrin-17 level is a useful dynamic marker for atrophic gastritis.

Tan H, Tan E World J Gastrointest Endosc. 2024; 16(11):623-626.

PMID: 39600554 PMC: 11586718. DOI: 10.4253/wjge.v16.i11.623.


Non-Invasive Markers for the Detection of Gastric Precancerous Conditions.

Romanczyk M, Osmola M, Link A, Druet A, Hemont C, Martin J Cancers (Basel). 2024; 16(12).

PMID: 38927959 PMC: 11202181. DOI: 10.3390/cancers16122254.


Precision peptide theranostics: developing - to -terminus optimized theranostics targeting cholecystokinin-2 receptor.

Rahimi M, Corlett A, Van Zuylekom J, Sani M, Blyth B, Thompson P Theranostics. 2024; 14(5):1815-1828.

PMID: 38505611 PMC: 10945332. DOI: 10.7150/thno.89701.


State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus.

Liu F, Wang S, Guo X, Ye Z, Zhang H, Li Z World J Diabetes. 2023; 14(6):632-655.

PMID: 37383590 PMC: 10294061. DOI: 10.4239/wjd.v14.i6.632.


A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area.

De Re V, Realdon S, Vettori R, Zaramella A, Maiero S, Repetto O Int J Mol Sci. 2023; 24(4).

PMID: 36834698 PMC: 9966253. DOI: 10.3390/ijms24043290.


References
1.
Moonka R, Zhou W, Bell Jr R . Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. J Gastrointest Surg. 1999; 3(2):134-40. DOI: 10.1016/s1091-255x(99)80022-5. View

2.
Varro A, Dockray G, Bate G, Vaillant C, Higham A, Armitage E . Gastrin biosynthesis in the antrum of patients with pernicious anemia. Gastroenterology. 1997; 112(3):733-41. DOI: 10.1053/gast.1997.v112.pm9041234. View

3.
Varner A, Modlin I, Walsh J . High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept. 1981; 1(4):289-96. DOI: 10.1016/0167-0115(81)90052-5. View

4.
Stone S, Mierke D, Jackson G . Evidence for a C-terminal structural motif in gastrin and its bioactive fragments in membrane mimetic media. Peptides. 2007; 28(8):1561-71. DOI: 10.1016/j.peptides.2007.07.009. View

5.
Black J, Kalindjian S . Gastrin agonists and antagonists. Pharmacol Toxicol. 2003; 91(6):275-81. DOI: 10.1034/j.1600-0773.2002.910602.x. View